Neil G. Berry

6.7k citations

117 papers · 4.8k indexed · h-index 38

Co-authors: Matthew J. Rosseinsky Paul M. O’Neill George R. Darling Darren Bradshaw Jianliang Xiao Dave J. Adams Stephen A. Ward Dmytro Antypov
Topics: Malaria Research and Control (19 papers)Metal-Organic Frameworks: Synthesis and Applications (17 papers)HIV/AIDS drug development and treatment (13 papers)
Cited by: Inorganic Chemistry Process Chemistry and Technology Organic Chemistry
Journals: Nature Science Proceedings of the National Academy of Sciences
Partner nations: United Kingdom United States Switzerland

In The Last Decade

Neil G. Berry

113 papers receiving 4.7k citations

Peers

Countries citing papers authored by Neil G. Berry

Since Specialization

Citations

This map shows the geographic impact of Neil G. Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil G. Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil G. Berry more than expected).

Fields of papers citing papers by Neil G. Berry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil G. Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil G. Berry. The network helps show where Neil G. Berry may publish in the future.

Co-authorship network of co-authors of Neil G. Berry

This figure shows the co-authorship network connecting the top 25 collaborators of Neil G. Berry. A scholar is included among the top collaborators of Neil G. Berry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil G. Berry. Neil G. Berry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Predicting the Mechanical Properties of Supramolecular Gels 2025 ·Advanced Materials ·(unknown),(unknown),(unknown),(unknown),B. Dietrich,(unknown),Dave J. Adams,Neil G. Berry	1
2	Inactivated Viral Vaccine BBV87 Protects Against Chikungunya Virus Challenge in a Non-Human Primate Model 2025 ·Viruses ·Sarah Kempster,David Ferguson,Claire Ham,Joanna Hall,Adrian Jenkins,(unknown),Simon L. Priestnall,Alejandro Suárez‐Bonnet,Pierre Roques,Roger Le Grand,(unknown),Sushant Sahastrabuddhe,(unknown),(unknown),Hyeon Seon Ahn,Deok Ryun Kim,(unknown),Raphaël M. Zellweger,Neil G. Berry,Neil Almond	2
3	Potent Preorganized Pyrazolidine Cyclophilin D Inhibitors Prevent Mitochondrial and Organ Injury in a Mouse Pancreatitis Disease Model 2025 ·Journal of Medicinal Chemistry ·(unknown),(unknown),(unknown),Michael S. Rogers,Neil M. Kershaw,Thomas Zacharchenko,(unknown),(unknown),Rajarshi Mukherjee,David N. Criddle,Suet C. Leung,Heather Lee,(unknown),Konstantin V. Luzyanin,Neil G. Berry,S.V. Antonyuk,Lu‐Yun Lian,Robert Sutton,Paul M. O’Neill	0
4	The Synthesis and Reactivity of Naphthoquinonynes 2024 ·Angewandte Chemie International Edition ·Renato L. Carvalho,James M. Wood,(unknown),Neil G. Berry,Eufrânio N. da Silva Júnior,John F. Bower	3
5	Optimizing drug discovery for snakebite envenoming via a high-throughput phospholipase A2 screening platform 2024 ·Frontiers in Pharmacology ·Laura-Oana Albulescu,Adam Westhorpe,Rachel H. Clare,(unknown),(unknown),Jeroen Kool,Neil G. Berry,Paul M. O’Neill,Nicholas R. Casewell	5
6	Impact of fluoroquinolones and aminoglycosides on P. aeruginosa virulence factor production and cytotoxicity 2022 ·Biochemical Journal ·(unknown),(unknown),(unknown),(unknown),Dominic P. Byrne,(unknown),Craig Winstanley,Neil G. Berry,David G. Fernig,Stephen B. Kaye	4
7	Development of Pyrazolopyrimidine Anti-Wolbachia Agents for the Treatment of Filariasis 2021 ·ACS Medicinal Chemistry Letters ·(unknown),Neil G. Berry,Gemma L. Nixon,Suet C. Leung,Peter J. H. Webborn,Mark C. Wenlock,Stefan Kavanagh,Andrew Cassidy,Rachel H. Clare,Darren A. N. Cook,Kelly L. Johnston,Louise Ford,Stephen A. Ward,Mark J. Taylor,W. David Hong,Paul M. O’Neill	6
8	Amino Acid Residues Determine the Response of Flexible Metal–Organic Frameworks to Guests 2020 ·Journal of the American Chemical Society ·Yong Yan,Elliot J. Carrington,Rémi Pétuya,George F. S. Whitehead,Ajay Verma,Rebecca K. Hylton,Chiu C. Tang,Neil G. Berry,George R. Darling,Matthew S. Dyer,Dmytro Antypov,Alexandros P. Katsoulidis,Matthew J. Rosseinsky	45
9	The Anisotropic Responses of a Flexible Metal–Organic Framework Constructed from Asymmetric Flexible Linkers and Heptanuclear Zinc Carboxylate Secondary Building Units 2019 ·Crystal Growth & Design ·Elliot J. Carrington,Rémi Pétuya,Rebecca K. Hylton,Yong Yan,Dmytro Antypov,George R. Darling,Matthew S. Dyer,Neil G. Berry,Alexandros P. Katsoulidis,Matthew J. Rosseinsky	6
10	Chemical control of structure and guest uptake by a conformationally mobile porous material 2019 ·Nature ·Alexandros P. Katsoulidis,Dmytro Antypov,George F. S. Whitehead,Elliot J. Carrington,Dave J. Adams,Neil G. Berry,George R. Darling,Matthew S. Dyer,Matthew J. Rosseinsky	277
11	New tools for evaluating protein tyrosine sulfation: tyrosylprotein sulfotransferases (TPSTs) are novel targets for RAF protein kinase inhibitors 2018 ·Biochemical Journal ·Dominic P. Byrne,Yong Li,(unknown),(unknown),Claire E. Eyers,Carrow I. Wells,David H. Drewry,William J. Zuercher,Neil G. Berry,David G. Fernig,Patrick A. Eyers	28
12	N,O- vs N,C-Chelation in Half-Sandwich Iridium Complexes: A Dramatic Effect on Enantioselectivity in Asymmetric Transfer Hydrogenation of Ketones 2018 ·ACS Catalysis ·Gang Zhou,(unknown),Craig M. Robertson,Ruixia Liu,Zhen Hua Li,Konstantin V. Luzyanin,Neil G. Berry,Weiping Chen,Jianliang Xiao	26
13	Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis, a Neglected Fungal Disease 2018 ·Antimicrobial Agents and Chemotherapy ·Gemma L. Nixon,Laura McEntee,Adam Johnson,Nicola Farrington,Sarah Whalley,Joanne Livermore,(unknown),(unknown),Jaclyn Bibby,Neil G. Berry,Jodi M. Lestner,(unknown),Andrew Owen,David G. Lalloo,Ian G. Charles,William Hope	36
14	In Situ Surface-Enhanced Infrared Spectroscopy to Identify Oxygen Reduction Products in Nonaqueous Metal–Oxygen Batteries 2017 ·The Journal of Physical Chemistry C ·J. Padmanabhan Vivek,Neil G. Berry,Jianli Zou,Richard J. Nichols,Laurence J. Hardwick	65
15	Towards depersonalized abacavir therapy 2015 ·AIDS ·Dean J. Naisbitt,(unknown),(unknown),Neil G. Berry,Alexandre S. Lawrenson,John Farrell,Philip Martin,Klaus Strebel,Andrew Owen,(unknown),Neil French,Stephen E. Clarke,Paul M. O’Neill,(unknown)	13
16	Guest‐Adaptable and Water‐Stable Peptide‐Based Porous Materials by Imidazolate Side Chain Control 2013 ·Angewandte Chemie ·Alexandros P. Katsoulidis,Kyo Sung Park,Dmytro Antypov,Carlos Martí‐Gastaldo,Gary J. Miller,John E. Warren,Craig M. Robertson,Frédéric Blanc,George R. Darling,Neil G. Berry,John A. Purton,Dave J. Adams,Matthew J. Rosseinsky	33
17	A novel drug for uncomplicated malaria: Targeted high throughput screening (HTS) against the type II NADH:ubiquinone oxidoreductase (PfNDH2) of Plasmodium falciparum 2010 ·Biochimica et Biophysica Acta (BBA) - Bioenergetics ·Nicholas Fisher,(unknown),Alison Mbekeani,Alison E. Shone,Gemma L. Nixon,Paul A. Stocks,Peter Gibbons,Richard K. Amewu,W. David Hong,Victoria Barton,(unknown),James Chadwick,(unknown),Ashley J. Warman,Raman Sharma,Neil G. Berry,Paul M. O’Neill,Stephen A. Ward,Giancarlo A. Biagini	1
18	Acridinediones: Selective and Potent Inhibitors of the Malaria Parasite Mitochondrial bc1 Complex 2008 ·Molecular Pharmacology ·Giancarlo A. Biagini,Nicholas Fisher,Neil G. Berry,Paul A. Stocks,Brigitte Meunier,Dominic P. Williams,(unknown),Patrick G. Bray,Andrew Owen,Paul M. O’Neill,Stephen A. Ward	66
19	A Medicinal Chemistry Perspective on 4-Aminoquinoline Antimalarial Drugs 2006 ·Current Topics in Medicinal Chemistry ·Patrick G. Bray,Byungwoo Park,(unknown),Giancarlo A. Biagini,(unknown),Neil G. Berry,Stephen A. Ward,(unknown)	78
20	HIV-2-specific cytotoxic T-lymphocyte activity is inversely related to proviral load 1995 ·AIDS ·Koya Ariyoshi,Fatim Cham,Neil G. Berry,Shabbar Jaffar,Sehu Sabally,Tumani Corrah,Hilton Whittle	35

About Neil G. Berry

Neil G. Berry is a scholar working on Inorganic Chemistry, Virology and Toxicology, having authored 117 papers that have together received 4.8k indexed citations. Recurring topics across this work include Malaria Research and Control (19 papers), Metal-Organic Frameworks: Synthesis and Applications (17 papers) and HIV/AIDS drug development and treatment (13 papers). The work is most often cited by research in Inorganic Chemistry (1.6k citations), Process Chemistry and Technology (236 citations) and Organic Chemistry (1.4k citations). Neil G. Berry has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Matthew J. Rosseinsky, Paul M. O’Neill, George R. Darling, Darren Bradshaw, Jianliang Xiao, Dave J. Adams, Stephen A. Ward, Dmytro Antypov, Jean‐Noël Rebilly and J.P. Barrio. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact